University of Alabama at Birmingham
Addiction Recovery Program
1713 6th Avenue South, Birmingham, AL 35249
University of Alabama at Birmingham Addiction Recovery Program is an intensive outpatient and outpatient facility in Birmingham, AL offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, TRICARE, Medicare, and private insurance.
Licenses and accreditations
- The Joint CommissionAccredited by The Joint Commission.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Intensive outpatient treatment
- Several hours of treatment a day, several days a week, while living at home.
- Outpatient
- Regular appointments while living at home.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Naltrexone used in Treatment
- Naltrexone is used here.
- Accepts clients using MAT but prescribed elsewhere
- Accepts clients whose medication for opioid use is prescribed elsewhere.
- Buprenorphine maintenance
- Buprenorphine continued over time to prevent relapse.
- Lofexidine or Clonidine detoxification
- Lofexidine or clonidine to ease withdrawal during detox.
- Maintenance service with medically supervised withdrawal after stabilization
- Medication maintained, then tapered under medical supervision once stable.
- Prescribes buprenorphine
- Prescribes buprenorphine.
- Prescribes naltrexone
- Prescribes naltrexone.
- Relapse prevention with naltrexone
- Naltrexone to help prevent relapse.
Payment
- Accepted
- Cash or self-payment; TRICARE and other federal military insurance; Medicare; Private health insurance.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
More details this facility reports
- Hospitals
- General Hospital (including VA hospital).
- External Opioid Medications Source
- In-network prescribing entity; No formal relationship with prescribing entity; Other contracted prescribing entity.
- Type of Alcohol Use Disorder Treatment
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity; No formal relationship with prescribing entity; Other contracted prescribing entity.
- Pharmacotherapies
- Acamprosate (Campral®); Buprenorphine (extended-release, injectable); Buprenorphine sub-dermal implant; Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Disulfiram; Medication for mental disorders; Naltrexone (extended-release, injectable); Naltrexone (oral); Nicotine replacement; Non-nicotine smoking/tobacco cessation.
- Treatment Approaches
- 12-step facilitation; Anger management; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling.
- Facility Operation (e.g., Private, Public)
- State government.
- Assessment/Pre-treatment
- Comprehensive substance use assessment; Screening for substance use.
- Testing
- Breathalyzer or blood alcohol testing; Drug or alcohol urine screening.
- Transitional Services
- Aftercare/continuing care; Discharge Planning.
- Recovery Support Services
- Mentoring/peer support.
- Education and Counseling Services
- Family counseling; Group counseling; Individual counseling; Marital/couples counseling; Substance use disorder education.
- Facility Smoking Policy
- Smoking permitted in designated area.
- Facility Vaping Policy
- Vaping permitted in designated area.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.